INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 1 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 788,175 | $10,199,000 | 4.68% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,987,313 | $116,296,000 | 2.40% |
| Antipodean Advisors LLC | 305,294 | $3,951,000 | 2.39% |
| Freshford Capital Management, LLC | 475,984 | $6,159,000 | 1.81% |
| Folger Hill Asset Management LP | 1,597,945 | $20,677,000 | 1.61% |
| JW Asset Management, LLC | 150,638 | $1,949,000 | 1.55% |
| 12 West Capital Management LP | 623,791 | $8,072,000 | 1.30% |
| Orbimed Advisors | 4,688,240 | $60,666,000 | 0.63% |
| CYPRESS FUNDS LLC | 135,584 | $1,754,000 | 0.41% |
| Rock Springs Capital Management LP | 365,500 | $4,730,000 | 0.35% |